SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (1596)11/5/1998 3:22:00 PM
From: Dr. John M. de Castro  Read Replies (2) of 2742
 
Back where we started.
CIST stock price has now reverted to the level it was at prior to the announcement of the signing of the PMC deal. It doesn't seem to matter that the company is $2 million richer, that they've received a major pharma endorsement of the legitimacy of their technology, and that the stock is selling for below cash value.

CIST is now selling below the level quoted in the headline of this thread "Cistron Biotechnology(CIST)$.30" that was created in Oct 7 1996, before the PMC deal and even before the IMNX settlement. This is totally irrational and rediculous to value this company at a lower level than 1996 when CIST had nothing but a hope and a prayer that litigation would keep them from bankruptcy.

It is now clear to me why so few companies ever get off the bulletin board. The market won't let you. Even when you succeed you don't receive any premium. But, if you fail the bottom drops out. I can see why the MMs can short these stocks with impunity. The bulletin board is a corporate trap, like the "Hotel California" "you can check out anytime you want, but you can never leave."

Is my frustration showing? :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext